Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ghaem Darou is a prominent Iranian pharmaceutical company specializing in the development and manufacture of standardized herbal medicines. The company bridges the gap between traditional Persian medicine and modern pharmacology by producing clinically-tested botanical extracts for a variety of therapeutic areas. Their portfolio includes specialized treatments for Alzheimer's disease, diabetes, obesity, and migraine, often utilizing indigenous plant species. As a certified knowledge-based company, Ghaem Darou emphasizes scientific validation and quality control in its manufacturing processes. Their products are widely distributed in the Iranian market and are increasingly targeted for international export. The company maintains state-of-the-art facilities that comply with Good Manufacturing Practices (GMP) for natural products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ghaem Darou.